KLRA
Kailera Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
No implied move.
Kailera Therapeutics, Inc.
Expected move
No implied move.
No implied move.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Bain Capital InvestorsBain Capital Investors | $578.4M | 22.63% | new | |
| 2 | Bain Capital Life Sciences InvestorsBain Capital Life Sciences Investors | $497.5M | 19.47% | new | |
| 3 | RTW InvestmentsRTW | $237.4M | 9.29% | new | |
| 4 | Canada Pension Plan Investment BoardCanada Pension Plan Investment Board | $160.9M | 6.30% | new | |
| 5 | Atlas Venture Life Science AdvisorsAtlas Venture Life Science | $113.9M | 4.46% | new | |
| 6 | FMRFMR | $87.5M | 3.42% | new | |
| 7 | BlackRockBlackRockindex-like | $86.5M | 3.39% | new | |
| 8 | T. Rowe Price AssociatesT. Rowe Price | $77.9M | 3.05% | new | |
| 9 | Citadel AdvisorsCitadel | $71.4M | 2.79% | new | |
| 10 | Adage Capital Partners GPAdage Capital Partners GP | $70.7M | 2.77% | new | |
| 11 | Wellington Management GroupWellington | $64.3M | 2.52% | new | |
| 12 | Royalty Pharma Sub-ManagerRoyalty Pharma Sub-Manager | $54.1M | 2.12% | new | |
| 13 | SirenSiren | $48.8M | 1.91% | new | |
| 14 | Vanguard Capital ManagementVanguardindex-like | $37.3M | 1.46% | new | |
| 15 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $36.4M | 1.42% | new | |
| 16 | Geode Capital ManagementGeodeindex-like | $25.0M | 0.98% | new | |
| 17 | Farallon Capital ManagementFarallon | $24.2M | 0.95% | new | |
| 18 | Frazier Life Sciences ManagementFrazier Life Sciences | $24.2M | 0.95% | new | |
| 19 | Trails Edge Capital PartnersTrails Edge Capital Partners | $21.7M | 0.85% | new | |
| 20 | UBS GroupUBS | $21.4M | 0.84% | new | |
| 21 | Jupiter TopcoJupiter Topco | $21.3M | 0.84% | — | |
| 22 | Ameriprise FinancialAmeriprise Financial | $18.1M | 0.71% | new | |
| 23 | Deep Track CapitalDeep Track Capital | $15.4M | 0.60% | new | |
| 24 | Eventide Asset ManagementEventide | $13.6M | 0.53% | new | |
| 25 | Vestal Point CapitalVestal Point Capital | $12.7M | 0.50% | new |
No implied move.
No thesis.
Kailera Therapeutics, Inc.
12.67
99 managers report $2.6B of Kailera Therapeutics on form 13F for the quarter ended Jun 30 '26. 11 of them hold 80% of it; Bain Capital Investors is largest at 22.63%.